Creative Biolabs has announced the expansion of its custom oligosaccharide synthesis and glycan characterization services, aiming to support researchers in drug discovery, vaccine development, and biomarker studies. The company combines chemical, enzymatic, and chemoenzymatic synthesis technologies with comprehensive analytical platforms, including mass spectrometry (MS), high-performance liquid chromatography (HPLC), and nuclear magnetic resonance (NMR), to deliver structurally defined oligosaccharides.
Oligosaccharides play critical roles in cell signaling, immune regulation, pathogen-host interactions, and disease progression, making them valuable tools for therapeutic, vaccine, and diagnostic research. However, their structural complexity continues to complicate synthesis, purification, and characterization. According to a scientist from Creative Biolabs, 'The structural complexity of oligosaccharides continues to present significant challenges for researchers developing next-generation therapeutics. By integrating custom synthesis with comprehensive analytical characterization, we help researchers obtain structurally validated glycans that support reliable downstream studies and accelerate scientific discovery.'
The company offers a broad portfolio of services, including custom oligosaccharide synthesis of high-purity oligosaccharides, complex glycans, tumor-associated carbohydrate antigens (TACAs), and functionalized carbohydrate derivatives. Advanced glycan characterization using MS, HPLC, and NMR determines glycan structures, linkage patterns, sequences, and purity. Additionally, Creative Biolabs provides application-oriented carbohydrate design for structural biology, glycoprotein research, biomarker discovery, immunology, targeted drug delivery, and therapeutic development.
Researchers utilizing Creative Biolabs' glycan services have highlighted both the quality of the synthesized products and the comprehensive technical support provided throughout their projects. In one recent project, researchers required a complex glycan structure that was not readily available through standard commercial sources. Integrated synthesis and analytical characterization helped support downstream structural confirmation.
By combining custom carbohydrate synthesis with rigorous analytical characterization under one integrated platform, Creative Biolabs helps researchers reduce technical risks, improve experimental reproducibility, support more efficient project progression, and accelerate scientific innovation. Researchers can explore customized oligosaccharide synthesis and glycan characterization options through Creative Biolabs' glycobiology platform at https://www.creative-biolabs.com/glycoprotein/.
